More medical and healthcare stocks are joining lists of top stocks to buy, including Indivior. Its products help decrease opioid abuse.
Research
IBD 50 Stock Indivior Breaks Out Amid Big Fund Ownership Expansion, Strong Profit Prospects
Licensing
DAVID SAITO-CHUNG
11:24 AM ET 06/25/2026
Indivior Pharmaceuticals Inc. (INDV) possesses solid growth attributes, which could help it handily outperform the market.
Opioid addiction has cast a shadow over the U.S. But pharma stock Indivior Pharmaceuticals is eyeing a fresh entry as profits…
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its…
Healthcare stocks are attracting attention in a market broadening beyond AI-driven tech names, and now make up a big chunk of the…
AI data center play shows triple-digit earnings growth and accelerating sales.
Weight-loss giant deepening its focus on gene editing, vaccines and cancer.
